A recent report on Drug Delivery Devices Market provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and latest growth trends accepted by key players that form a part of the competitive spectrum of this business.
"Global Drug Delivery Devices Market is valued at USD 1349.59 billion in 2019 and expected to reach USD 2208.52 billion by 2026 with the CAGR of 6.35% over the forecast period."
Drug delivery devices are specialized devices used for delivery of a drug or therapeutic agent by a specific route of administration which is defined as the path by which a drug, fluid, poison, or other substance is taken into the body. These devices are mainly used to reach the drug or medicaments to the site of action through particular way on the basis of disease type, dosage form, target sites etc. These devices help in increasing the activity of drug delivery system by controlling time, dosage form, dose and releasing site of the drugs & action site in the body. Major features of these devices include target specificity, specific therapeutic effect, dose-optimization and high degree of safety.
Key Players for Global Drug Delivery Devices Market Report-
Some major key players for global drug delivery devices market are F. Hoffmann-La Roche Ltd, Antares Pharma, Novartis AG, 3M, Gerresheimer AG, Sanofi, Enable Injections, Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, GlaxoSmithKline Plc., Novosanis, MEDMIX SYSTEMS AG, Pfizer Inc., Sulzer Ltd, Insulet Corporation, OraSure Technologies, Inc., West Pharmaceutical Services Inc., SMC Ltd., ViVO Smart Medical Devices Ltd. and others.
Global Drug Delivery Devices Market Regional Analysis–
North America is expected to dominate the global drug delivery devices market with highest market share due to availability of world class approval systems such as FDA, support & funding from the government in research & development activities as well as physicians preference for drug delivery devices over other therapies in this region. For instance; the American Cancer Society projected that 1,762,450 new cancer cases and 606,880 cancer deaths in the United States in 2019 and for treatment of this disease physicians use varies drug delivery devices which in turn propels the market growth.
Key Benefits for Global Drug Delivery Devices Market Report–
Global Drug Delivery Devices Market Segmentation:–
By Route of Administration:
Get Sample Copy of This Premium Report@https://brandessenceresearch.com/requestSample/PostId/1137
Interested in this report?